Review of Medicines and Medical Devices Regulation
The Panel comprises of Emeritus Professor Lloyd Sansom AO (Chair), Mr Will Delaat AM and Professor John Horvath AO. A discussion paper was developed summarising various stakeholders’ concerns about the regulation of medicines and medical devices and options. This discussion paper was released in November 2014 and interested organisations and individuals were invited to provide submissions addressing the issues and options raised in the paper.
Copies of submissions received to date are available.
The Panel is now developing its recommendations and would like your input.
Health consumers are invited to meet with members of the Panel in Melbourne on the morning of Thursday 19 February 2015 (time and venue to be confirmed) to raise any issues that you feel may be of interest to the Panel in formulating its recommendations.
While the Panel members would welcome consumer input on any of the issues and themes raised in the discussion paper, they would particularly like to focus on:
- Early/accelerated access schemes and the associated risks and benefits;
- Utilisation of assessments of medicines and medical devices made by overseas regulators;
- Post market surveillance – opportunities to enhance and what this may mean for consumers, in particular linkage of data sets such as the Medicare and PBS data sets and use of E Health records.
- Advertising of S3 drugs direct to consumers.
If you wish to attend the forum please contact the Review Secretariat by email or call (02) 6289 4359 by Wednesday, 11 February 2015.
Subscribe to Full Circle
Our monthly newsletter